TRPM5 and neoplasm: In particular, reduced TRPM5 activity leads to an increase in cytosolic Ca2+ concentration, which stimulates proliferative pathways and the production of inflammatory cytokines such as IL-6 and CXCL10, with particularly marked effects at the invasive edges of the tumor [39].